Target intelligence / Profile preview

Lysosomal amino acid transporter 1 homolog (SLC66A1)

Target
SLC66A1
Molecular classification
Transporter, Transceptor (transporter with receptor-like/sensor function)
01

Overview

Lysosomal amino acid transporter 1 homolog (SLC66A1, also known as PQLC2 or LAAT-1) is a lysosomal transmembrane protein that functions as a pH-dependent transporter to export cationic amino acids—specifically arginine, lysine, and histidine—from the lysosomal lumen to the cytosol[2][5][7]. This activity is essential for maintaining intracellular amino acid homeostasis and supporting cellular metabolism[2][4][6]. In addition to its transporter activity, SLC66A1 also acts as a sensor—a “transceptor”—by detecting lysosomal cationic amino acid depletion and subsequently recruiting the C9orf72-SMCR8-WDR41 protein complex to the lysosomal surface[1][3][4][8]. This recruitment is critical for lysosome-based signaling, including impacts on mTORC1 activity and potentially on neuronal cell homeostasis[1][4]. Loss-of-function mutations in SLC66A1 cause inherited retinal disorders such as autosomal recessive retinitis pigmentosa, while dysregulation (such as upregulation in cancers) is associated with tumorigenesis and poor prognosis in gastric cancer[6]. There are currently no established drugs that directly target SLC66A1, and no validated biomarkers or specific safety concerns have been described in the context of therapy.

Other names
PQLC2LAAT-1LAAT1PQ-loop repeat-containing protein 2FLJ20320PQ loop repeat containing 2solute carrier family 66 member 1
02

Biological functions

pH-dependent export of cationic amino acids (arginine, lysine, histidine) from lysosomeAmino acid homeostasisSensing of cationic amino acid levels in lysosomeRecruitment of C9orf72-SMCR8-WDR41 complex to lysosomal membrane
03

Disease associations

Retinal disease (autosomal recessive retinitis pigmentosa, rod-cone dystrophy)Cancer (notably gastric cancer associated with upregulation)Other (potential links to neurometabolic or neurodegenerative disease, under investigation)

Beyond the preview

Go deeper on Lysosomal amino acid transporter 1 homolog (SLC66A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosomal amino acid transporter 1 homolog (SLC66A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call